Trial Profile
Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST): a randomised controlled trial of thrombolytic treatment with tenecteplase for acute ischaemic stroke upon awakening
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Feb 2024
Price :
$35
*
At a glance
- Drugs Tenecteplase (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms TWIST
- 31 Jan 2024 This trial has been Completed in Denmark, According to European Clinical Trials Database record.
- 01 Feb 2023 Primary endpoint (Functional outcome at 3 months.) has not been met, according to Results published in the Lancet Neurology.
- 01 Feb 2023 Results published in the Lancet Neurology